26/8/2024, 10:44:03 am

Zydus Life shares fall 6%, brokerages neutral on Sterling Biotech deal

Zydus Lifesciences shares fell up to 6% on Monday to day's low at Rs 1,109 on BSE after the company announced acquisition of 50% stake in Sterling Biotech from existing owner Perfect Day for Rs 550 crore. Nomura maintained its neutral stance with a target price of Rs 1,020 while Motilal Oswal also stuck to a neutral tone with a target price of Rs 1,210.